Workup for Elevated Ferritin
The most critical first step is to measure fasting transferrin saturation (TS) alongside ferritin, because over 90% of elevated ferritin cases are NOT due to iron overload but rather inflammation, liver disease, malignancy, or metabolic conditions—and TS ≥45% is the key discriminator for true iron overload requiring genetic testing. 1, 2
Initial Laboratory Evaluation
When ferritin is elevated, immediately order the following tests:
- Fasting transferrin saturation (TS) - the single most important test to distinguish iron overload from secondary causes 1, 2
- Complete blood count with differential 2
- Comprehensive metabolic panel including AST, ALT - to assess hepatocellular injury 1, 2
- Inflammatory markers: CRP and ESR - to detect occult inflammation 1, 2
- Creatine kinase (CK) - to evaluate for muscle necrosis 1
Algorithmic Approach Based on Transferrin Saturation
If TS ≥45%: Suspect Primary Iron Overload
- Order HFE genetic testing for C282Y and H63D mutations to diagnose hereditary hemochromatosis 1, 2
- C282Y homozygotes with elevated iron stores confirm HFE hemochromatosis and can proceed to therapeutic phlebotomy 1, 2
- Consider liver MRI to quantify hepatic iron concentration if diagnosis remains uncertain 2, 3
- Liver biopsy should be offered to C282Y homozygotes with ferritin >1000 μg/L, elevated AST, hepatomegaly, or age >40 years 1
- Screen first-degree relatives with genetic testing once HFE hemochromatosis is confirmed 1, 2
If TS <45%: Investigate Secondary Causes (>90% of Cases)
The following conditions account for the vast majority of elevated ferritin 1, 2:
Liver Disease:
- Chronic alcohol consumption - obtain detailed alcohol history 1, 2
- Non-alcoholic fatty liver disease (NAFLD)/metabolic syndrome - check blood pressure, BMI, cholesterol, triglycerides, fasting glucose 1, 2
- Viral hepatitis B or C - order hepatitis serologies 2
- Acute hepatitis - elevated transaminases suggest hepatocellular necrosis 1, 2
Inflammatory/Infectious Conditions:
- Active infection - ferritin rises acutely as an acute phase reactant 2
- Chronic inflammatory diseases - evaluate based on clinical presentation 1, 2
- Adult-onset Still's disease (AOSD) - consider if ferritin >10,000 μg/L; order glycosylated ferritin fraction (≤20% is 93% specific for AOSD) 2, 4, 5
Malignancy:
Other Causes:
Risk Stratification by Ferritin Level
Ferritin <1000 μg/L:
- Low risk of organ damage (94% negative predictive value for advanced fibrosis) 2
- If C282Y homozygote with elevated TS, can initiate therapeutic phlebotomy without liver biopsy 1, 2
Ferritin 1000-10,000 μg/L:
- Higher risk of advanced fibrosis/cirrhosis if iron overload present 2
- The combination of ferritin >1000 μg/L, elevated aminotransferases, and platelet count <200 predicts cirrhosis in 80% of C282Y homozygotes 2
- Consider liver biopsy in this setting 1, 2
Ferritin >10,000 μg/L:
- Rarely represents simple iron overload 2
- Requires urgent specialist referral to evaluate for life-threatening conditions including AOSD, hemophagocytic lymphohistiocytosis, or severe infection 2, 4, 5
Critical Pitfalls to Avoid
- Never use ferritin alone to diagnose iron overload - ferritin is an acute phase reactant elevated in inflammation, liver disease, malignancy, and tissue necrosis independent of iron stores 1, 2
- Do not assume iron overload when TS <45% - in the general population, iron overload is NOT the most common cause of elevated ferritin 2
- Do not overlook liver biopsy in patients with ferritin >1000 μg/L and abnormal liver tests, as this combination warrants histologic assessment for cirrhosis 2
- Recognize that extremely high ferritin (>10,000 μg/L) rarely represents simple iron overload and requires evaluation for inflammatory/rheumatologic emergencies 2, 4
Special Considerations
In patients with chronic kidney disease:
- Elevated ferritin with low TS (<20%) may represent functional iron deficiency that responds to IV iron therapy 1, 2
- Consider a trial of weekly IV iron (50-125 mg for 8-10 doses) to differentiate functional iron deficiency from inflammatory block 2
In patients with inflammatory bowel disease: